Scinvivo secures 1 million investment towards in human clinical trials and CE

Eindhoven, March 10th, 2022 Scinvivo, a MedTech startup based in Eindhoven, has closed an investment round of 1 Million Euro from NextStage Early Stage Fund (NSESF), Innovatiefonds Noord-Holland and current shareholders. With this investment Scinvivo has secured the development of in human clinical trials and CE certification. Scinvivo is on a mission to make cancer…

Read More